Proactive Investors - Run By Investors For Investors

Propanc at final stages of completing manufacturing steps to file first clinical trial application

Propanc Biopharma, Inc. (OTCQB: PPCB) CEO James Nathanielsz sat down with Proactive Investors at the BIO CEO and Investor Conference in New York.

The biopharmaceutical company is developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers.

 
Meet West Wits Mining Limited, Global Energy Ventures Ltd, XTEK Ltd and ShareRoot Ltd at our event, Melbourne , 04 June 2019. Register here »
View full PPCB profile View Profile

Propanc Biopharma Inc Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use